Taiwan Kyowa Kirin Co., Ltd. is a subsidiary of Kyowa Kirin Co., Ltd. established in Taiwan in 1991 and is a member of Kirin Holding Group of Japan. We are committed towards our patient health and their well-being through innovative drug discovery and global commercialisation, driven by state-of-the-art antibody technologies, in the core therapeutic areas of: Nephrology, Oncology, Immunology & Allergy, and Central Nervous System.

Our goal is clear: to do everything we can to answer the unmet medical needs of patients, their families, and medical professionals, and to do it as quickly as possible. Because every moment counts.